| 000 | 01820 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514022224.0 | ||
| 264 | 0 | _c20020624 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a0743-5800 | ||
| 024 | 7 |
_a10.1081/erc-100107870 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOnobrakpeya, O A | |
| 245 | 0 | 0 |
_aEffect of norethindrone acetate on hormone levels and markers of bone turnover in estrogen-treated postmenopausal women. _h[electronic resource] |
| 260 |
_bEndocrine research _cNov 2001 |
||
| 300 |
_a473-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
| 650 | 0 | 4 |
_aBone and Bones _xenzymology |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCollagen _xurine |
| 650 | 0 | 4 |
_aCollagen Type I _xblood |
| 650 | 0 | 4 | _aEstrogen Replacement Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFollicle Stimulating Hormone _xblood |
| 650 | 0 | 4 |
_aHormones _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xblood |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
| 650 | 0 | 4 |
_aNorethindrone _xadministration & dosage |
| 650 | 0 | 4 | _aNorethindrone Acetate |
| 650 | 0 | 4 |
_aOsteocalcin _xblood |
| 650 | 0 | 4 |
_aPeptides _xurine |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 |
_aSex Hormone-Binding Globulin _xanalysis |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aFall, P M | |
| 700 | 1 | _aWillard, A | |
| 700 | 1 | _aChakravarthi, P | |
| 700 | 1 | _aHansen, A | |
| 700 | 1 | _aRaisz, L G | |
| 773 | 0 |
_tEndocrine research _gvol. 27 _gno. 4 _gp. 473-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1081/erc-100107870 _zAvailable from publisher's website |
| 999 |
_c11705583 _d11705583 |
||